Literature DB >> 34724113

An autophagy-related lncRNA prognostic risk model for thyroid cancer.

Yanan Shan1,2, Ran He1,2, Xiaowei Yang1,2, Siwen Zang1,2, Shan Yao1,2, Min Gao1,2, Sixuan Li1,2, Zhihua Yin3,4,5.   

Abstract

PURPOSE: Thyroid cancer (TC) is the most common malignancy of the endocrine system and its incidence is gradually rising. Research has demonstrated a close link between autophagy and thyroid cancer. We constructed a prognostic model of autophagy-related long non-coding RNA (lncRNA) in thyroid cancer and explored its prognostic value.
METHODS: The data used in this study were all obtained from The Cancer Genome Atlas (TCGA) database and the Human Autophagy Database (HADb). We construct a co-expression network by autophagy-related genes and lncRNA to obtain autophagy-related lncRNAs. After univariate Cox regression analysis and multivariate Cox regression analysis, autophagy-related lncRNAs significantly associated with prognosis were identified. Based on the risk score of lncRNA, thyroid cancer patients are divided into high-risk group and low-risk group.
RESULTS: A total of 14,142 lncRNAs and 212 autophagy-related genes (ATGs) were obtained from the TCGA database and the HADb, respectively. We performed lncRNA-ATGs correlation analysis and finally obtained 1,166 autophagy-associated lncRNAs. Subsequently, we conducted univariate Cox regression analysis and multivariate Cox regression analysis, nine autophagy-related lncRNAs (AC092279.1, AC096677.1, DOCK9-DT, LINC02454, AL136366.1, AC008063.1, AC004918.3, LINC02471 and AL162231.2) significantly associated with prognosis were identified. Based on these autophagy-related lncRNAs, a risk model was constructed. The area under the curve (AUC) of the risk score was 0.905, proving that the accuracy of risk signature was superior. In addition, multiple regression analysis showed that risk score was a significant independent prognostic risk factor for thyroid cancer.
CONCLUSION: In this study, nine autophagy-related lncRNAs in thyroid cancer were established to predict the prognosis of thyroid cancer patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  LncRNA; Prognostic; TCGA; Thyroid cancer

Mesh:

Substances:

Year:  2021        PMID: 34724113     DOI: 10.1007/s00405-021-07134-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

1.  Rare thoracic cancers, including peritoneum mesothelioma.

Authors:  Sabine Siesling; Jan Maarten van der Zwan; Isabel Izarzugaza; Jana Jaal; Tom Treasure; Roberto Foschi; Umberto Ricardi; Harry Groen; Andrea Tavilla; Eva Ardanaz
Journal:  Eur J Cancer       Date:  2012-03-09       Impact factor: 9.162

Review 2.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

3.  Recent incidences and differential trends of thyroid cancer in the USA.

Authors:  Yushan Mao; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2016-02-25       Impact factor: 5.678

Review 4.  Thyroid cancer.

Authors:  Maria E Cabanillas; David G McFadden; Cosimo Durante
Journal:  Lancet       Date:  2016-05-27       Impact factor: 79.321

Review 5.  Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?

Authors:  Panagiotis Anagnostis; Stavroula A Paschou; Dimitrios G Goulis; Vasilios G Athyros; Asterios Karagiannis
Journal:  Maturitas       Date:  2017-11-14       Impact factor: 4.342

Review 6.  Autophagy: assays and artifacts.

Authors:  Sandra Barth; Danielle Glick; Kay F Macleod
Journal:  J Pathol       Date:  2010-06       Impact factor: 7.996

7.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 8.  Mechanism and medical implications of mammalian autophagy.

Authors:  Ivan Dikic; Zvulun Elazar
Journal:  Nat Rev Mol Cell Biol       Date:  2018-06       Impact factor: 94.444

9.  Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production.

Authors:  Christopher Hine; Hyo-Jeong Kim; Yan Zhu; Eylul Harputlugil; Alban Longchamp; Marina Souza Matos; Preeti Ramadoss; Kevin Bauerle; Lear Brace; John M Asara; C Keith Ozaki; Sheue-Yann Cheng; Subhankar Singha; Kyo Han Ahn; Alec Kimmelman; Ffolliott M Fisher; Pavlos Pissios; Dominic J Withers; Colin Selman; Rui Wang; Kelvin Yen; Valter D Longo; Pinchas Cohen; Andrzej Bartke; John J Kopchick; Richard Miller; Anthony N Hollenberg; James R Mitchell
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

10.  Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma.

Authors:  Haruhiko Yamazaki; Hiroyuki Iwasaki; Nobuyasu Suganuma; Soji Toda; Katsuhiko Masudo; Hirotaka Nakayama; Yasushi Rino; Munetaka Masuda
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-10-01
View more
  4 in total

1.  Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma.

Authors:  Runming Pang; Chunxin Qin
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-03       Impact factor: 2.650

2.  A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.

Authors:  Jin-Ming Yao; Jun-Yu Zhao; Fang-Fang Lv; Xue-Bo Yang; Huan-Jun Wang
Journal:  Pathol Oncol Res       Date:  2022-02-23       Impact factor: 3.201

3.  A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma.

Authors:  Jian Hou; Zhenquan Lu; Runan Dong; Guoqing Wu; Haibo Nie; Guang Yang; Cheng Tang; Genyi Qu; Yong Xu
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

4.  A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.

Authors:  Qilin Li; Weimin Chen; Qiuhui Li; Jing Mao; Xin Chen
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.